BioMimetic Therapeutics higher despite Q4 loss
Shares of BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) opened in the red but managed to climb into positive territory despite news of a wider fourth-quarter loss. The Franklin, Tenn.-based maker of products for the healing of musculoskeletal injuries and disease reported after the close on Wednesday that its loss for the three months ended Dec. 31, 2007, was $6.9 million or $0.37 per share, compared with a net loss of $5.3 million, or $0.34 per share, for the same period in 2006.
Six analysts polled by Thomson Financial were expecting a net loss of $0.31 per share. At 1:25 p.m. ET, the stock was up $0.23, or 2%, to $13.13.
Six analysts polled by Thomson Financial were expecting a net loss of $0.31 per share. At 1:25 p.m. ET, the stock was up $0.23, or 2%, to $13.13.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
